Activation of Sphingosine Kinase-1 in Cancer: Implications for Therapeutic Targeting

E-ISSN： 1874-4702|3|2|53-65

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.3, Iss.2, 2010-01, pp. : 53-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Downregulating sphingosine kinase-1 for cancer therapy

By Cuvillier Olivier

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 1009-1020

Informa Healthcare

Access to resources Recommend Favorite

Superior cervical ganglion-10 protein as a molecular effector of c-Jun N-terminal kinase 1: implications for the therapeutic targeting of Jun N-terminal kinase in nerve regeneration

By Westerlund Nina Zdrojewska Justyna Courtney Michael J Coffey Eleanor T

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 1, 2008-01 ,pp. : 31-43

Informa Healthcare

Access to resources Recommend Favorite

The Expression of Sphingosine Kinase-1 in Head and Neck Carcinoma

Cells Tissues Organs, Vol. 192, Iss. 5, 2010-07 ,pp. : 314-324

Karger

Access to resources Recommend Favorite

Sphingosine-1-phosphate: an emerging therapeutic target

By Toman R.E. Milstien S. Spiegel S.

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 1, 2001-02 ,pp. : 109-123

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors

Current Medicinal Chemistry, Vol. 23, Iss. 3, 2016-01 ,pp. : 242-264

Bentham Science Publishers

Access to resources Recommend Favorite